152 related articles for article (PubMed ID: 23464511)
1. De novo cancer-related death in Australian liver and cardiothoracic transplant recipients.
Na R; Grulich AE; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
Am J Transplant; 2013 May; 13(5):1296-304. PubMed ID: 23464511
[TBL] [Abstract][Full Text] [Related]
2. Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients.
Na R; Grulich AE; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
Am J Transplant; 2013 Jan; 13(1):174-83. PubMed ID: 23094788
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.
Na R; Laaksonen MA; Grulich AE; Webster AC; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
Clin Transplant; 2015 Nov; 29(11):978-90. PubMed ID: 26278925
[TBL] [Abstract][Full Text] [Related]
4. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
[TBL] [Abstract][Full Text] [Related]
5.
Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
[TBL] [Abstract][Full Text] [Related]
6. Cancer Mortality Among Recipients of Solid-Organ Transplantation in Ontario, Canada.
Acuna SA; Fernandes KA; Daly C; Hicks LK; Sutradhar R; Kim SJ; Baxter NN
JAMA Oncol; 2016 Apr; 2(4):463-9. PubMed ID: 26746479
[TBL] [Abstract][Full Text] [Related]
7. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
[TBL] [Abstract][Full Text] [Related]
8. Iatrogenic immunosuppression and risk of non-Hodgkin lymphoma in solid organ transplantation: A population-based cohort study in Australia.
Na R; Laaksonen MA; Grulich AE; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
Br J Haematol; 2016 Aug; 174(4):550-62. PubMed ID: 27136044
[TBL] [Abstract][Full Text] [Related]
9. High azathioprine dose and lip cancer risk in liver, heart, and lung transplant recipients: A population-based cohort study.
Na R; Laaksonen MA; Grulich AE; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
J Am Acad Dermatol; 2016 Jun; 74(6):1144-1152.e6. PubMed ID: 26830865
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of de novo cancer in liver transplant recipients.
Riis TH; Møller DL; Høgh J; Knudsen AD; Rostved AA; Akdag D; Kirkby N; Lassen U; Rasmussen A; Hillingsø JG; Pommergaard HC
APMIS; 2023 Apr; 131(4):135-141. PubMed ID: 36680559
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.
Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S
PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Mortality in Kidney Transplant Patients: A Population-based Cohort Study 1988-2013 in Australia and New Zealand.
Wyld MLR; De La Mata NL; Masson P; O'Lone E; Kelly PJ; Webster AC
Transplantation; 2021 Feb; 105(2):413-422. PubMed ID: 32168042
[TBL] [Abstract][Full Text] [Related]
13. De novo malignances in pediatric organ transplant recipients.
Penn I
Pediatr Transplant; 1998 Feb; 2(1):56-63. PubMed ID: 10084762
[TBL] [Abstract][Full Text] [Related]
14. De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications.
Lentine KL; Schnitzler MA; Abbott KC; Li L; Burroughs TE; Irish W; Brennan DC
Am J Kidney Dis; 2005 Oct; 46(4):720-33. PubMed ID: 16183428
[TBL] [Abstract][Full Text] [Related]
15. Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients.
Dahle DO; Grotmol T; Leivestad T; Hartmann A; Midtvedt K; Reisæter AV; Mjøen G; Pihlstrøm HK; Næss H; Holdaas H
Transplantation; 2017 Oct; 101(10):2599-2605. PubMed ID: 28207636
[TBL] [Abstract][Full Text] [Related]
16. De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation.
Aseni P; Vertemati M; De Carlis L; Sansalone CV; Bonacina E; Minola E; Oreste P; Vizzotto L; Rondinara G
Pathol Int; 2006 Nov; 56(11):712-5. PubMed ID: 17040297
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporin versus tacrolimus for liver transplanted patients.
Haddad EM; McAlister VC; Renouf E; Malthaner R; Kjaer MS; Gluud LL
Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD005161. PubMed ID: 17054241
[TBL] [Abstract][Full Text] [Related]
18. Burden of de novo malignancy in the liver transplant recipient.
Chandok N; Watt KD
Liver Transpl; 2012 Nov; 18(11):1277-89. PubMed ID: 22887956
[TBL] [Abstract][Full Text] [Related]
19. The risk of cancer in kidney transplant recipients may be reduced in those maintained on everolimus and reduced cyclosporine.
Lim WH; Russ GR; Wong G; Pilmore H; Kanellis J; Chadban SJ
Kidney Int; 2017 Apr; 91(4):954-963. PubMed ID: 28109543
[TBL] [Abstract][Full Text] [Related]
20. Cancer mortality in kidney transplantation.
Kiberd BA; Rose C; Gill JS
Am J Transplant; 2009 Aug; 9(8):1868-75. PubMed ID: 19563337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
